Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2692834 | 0.86 | — | — | |
| SCHEMBL16657577 | 0.86 | — | — | |
| SCHEMBL18588303 | 0.86 | — | — | |
| SCHEMBL5467629 | 0.73 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL12957557 | 0.73 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL13049849 | 0.73 | — | — | |
| SCHEMBL2349094 | 0.73 | SMN1; SMN2 (0.39) | CA1CA2CA4KMT2ASMN1; SMN2 | |
| SCHEMBL5918265 | 0.73 | CA1 (0.32) | CA1CA2CA4KMT2ASMN1; SMN2 | |
| SCHEMBL8162448 | 0.73 | MAPT (0.37) | — | |
| SCHEMBL873396 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119752742-A | Pre-harvest physiological management method for improving color and smell quality of spirulina | 中国海洋大学 | 2025-04-04 | — | — | CN | disclosed |
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | disclosed |
| US-20030149293-A1 | Method for producing 1,3-cyclohexanediol compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1333019-A1 | Method for producing 1,3-cyclohexanediol compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-08-06 | — | — | EP | disclosed |
| EP-0061669-B1 | PROCESS FOR THE PREPARATION OF CYCLOHEXANE-1,3-DIONES, AND SOME BICYCLIC CYCLOHEXANE-1,3-DIONES | BASF Aktiengesellschaft (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0061669-A1 | Process for the preparation of cyclohexane-1,3-diones, and some bicyclic cyclohexane-1,3-diones | BASF Aktiengesellschaft (DE) | 1982-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | ALPI, SI, SLC5A11 | CA1 315/4885CA2 346/4885CA4 490/4885 |
| US-20030149293-A1 | Method for producing 1,3-cyclohexanediol compound | NISCH, HSD11B2, ACMSD | CA1 63/4885CA2 5/4885CA4 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.